ADPT

27.9300.43%
JR

Julie Rubinstein

President & COO

Ms. Julie Rubinstein is Member of Advisory Board of Gift of Life Biologics, Inc. Ms. Rubinstein has been President of Adaptive Biotechnologies Corporation since February 2018 and serves as its Chief Operating Officer since April 2023 and served as its Director. Prior to Adaptive Biotechnologies Corporation, Ms. Rubinstein served as Chief Business Officer from January 2016 to February 2018 and Head of Corporate and Business Development from April 2011 to January 2016. Prior to joining Adaptive Biotechnologies Corporation, Ms. Rubinstein held various worldwide commercial development roles at Pfizer Inc.’s Oncology division, primarily focusing on cancer immunotherapy. She also served in various roles with Johnson & Johnson Services, Inc., including in Europe. Ms. Rubinstein serves on the Board of Trustees for The Valerie Fund, a pediatric oncology organization in New Jersey and New York. Ms. Rubinstein holds an MBA from Harvard Business School and dual undergraduate degrees from The Wharton School and Annenberg School of Communications at the University of Pennsylvania.

Positions